Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, March 31, 2021
INTEGRA Biosciences celebrated the expansion of its state-of-the-art facility in Hudson, NH, with a community ribbon cutting ceremony.
read more
Wednesday, March 31, 2021
Albumedix announced they have entered into a distribution agreement with established and well recognized reagent supplier FUJIFILM Wako.
read more
Wednesday, March 31, 2021
TCR2 Therapeutics has signed a long-term, full-building lease with Alexandria Real Estate Equities for an existing 85,000 square foot cell therapy manufacturing facility in Rockville, Maryland.
read more
Wednesday, March 31, 2021
Crystec are pleased to announce the opening of a new subsidiary, Nantong Crystec Pharmaceutical R&D Co. Ltd., and research facility, located at Haimen Science and Technology Park in Haimen City, Jiangsu Province, China.
read more
Wednesday, March 31, 2021
Perigord announced Tech Mahindra has acquired a 70% stake in Perigord Life Science Solutions, a digital workflow and artwork, labelling and BPO services firm.
read more
Wednesday, March 31, 2021
Ajinomoto and Bright Peak Therapeutics announced a research collaboration and exclusive license agreement to incorporate AJICAP, Ajinomoto’s proprietary site-specific bioconjugation technology.
read more
SignalChem Lifesciences announces a collaboration with Merck to evaluate the combination of SLC-391, a selective AXL inhibitor developed by SignalChem, with KEYTRUDA, Merck’s anti-PD-1 therapy, in patients with advanced non-small cell lung cancer.
read more
LabVantage Solutions announced the appointment of Mikael Hagstroem as Chief Executive Officer.
read more
CyanVac announced they have selected Exothera for the development and manufacturing of their COVID-19 intranasal vaccine based on a proprietary parainfluenza virus 5 (PIV5) vector.
read more
Gamma Biosciences has announced two additions to the senior management team of Astrea Bioseparations.
read more
TrialScope has been selected by H. Lundbeck A/S as its partner for maintaining disclosure compliance.
read more
The FDA has proposed to include one additional bulk drug substance on the list of bulk drug substances that outsourcing facilities may use in drug compounding consistent with section 503B of the Federal Food, Drug and Cosmetic Act.
read more
PsyBio Therapeutics has initiated process development of its proprietary biosynthetic formulation of norbaeocystin in collaboration with the Advanced Biofuels and Bioproducts Process Development Unit.
read more
Abveris announced the release of antibody sequences specific to the SARS-CoV-2 spike (S) protein into the public domain for unrestricted use.
read more
Thermo Fisher Scientific announced a strategic technology collaboration to develop an integrated and comprehensive software automation platform for Thermo Fisher’s standardized COVID-19 Testing Platform.
read more